VRTX - VERTEX PHARMACEUTICALS INC / MA

QQQ $ 455.25 $ 2.72 (0.6 %)

DIA $ 409.08 $ 4.58 (1.13 %)

SPY $ 546.60 $ 1.93 (0.35 %)

TLT $ 99.96 $ 0.58 (0.58 %)

GLD $ 231.58 $ 0.97 (0.42 %)

Previous Close

$ 471.11

Open

$ 472.88

Bid

$ 470.82 x 200

Ask

-- x --

Day's Range

$ 468.98 - $ 473.78

52 Week Range

$ 341.85 - $ 510.64

Volume

1,090,355

Average Volume

Market Cap

120.79B

Beta (5Y Monthly)

$ 0.51

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-02-2024	06-30-2024	10-Q
2	05-07-2024	03-31-2024	10-Q
3	02-15-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-02-2023	06-30-2023	10-Q
6	05-02-2023	03-31-2023	10-Q
7	02-10-2023	12-31-2022	10-K
8	10-28-2022	09-30-2022	10-Q
9	08-05-2022	06-30-2022	10-Q
10	05-06-2022	03-31-2022	10-Q
11	02-09-2022	12-31-2021	10-K
12	11-03-2021	09-30-2021	10-Q
13	07-30-2021	06-30-2021	10-Q
14	04-30-2021	03-31-2021	10-Q
15	02-11-2021	12-31-2020	10-K
16	10-30-2020	09-30-2020	10-Q
17	07-31-2020	06-30-2020	10-Q
18	05-01-2020	03-31-2020	10-Q
19	02-13-2020	12-31-2019	10-K
20	10-31-2019	09-30-2019	10-Q
21	08-01-2019	06-30-2019	10-Q
22	05-01-2019	03-31-2019	10-Q
23	02-13-2019	12-31-2018	10-K
24	10-25-2018	09-30-2018	10-Q
25	07-26-2018	06-30-2018	10-Q
26	04-27-2018	03-31-2018	10-Q
27	02-15-2018	12-31-2017	10-K
28	10-30-2017	09-30-2017	10-Q
29	07-28-2017	06-30-2017	10-Q
30	04-28-2017	03-31-2017	10-Q
31	02-23-2017	12-31-2016	10-K
32	10-31-2016	09-30-2016	10-Q
33	08-01-2016	06-30-2016	10-Q
34	05-03-2016	03-31-2016	10-Q
35	02-16-2016	12-31-2015	10-K
36	10-30-2015	09-30-2015	10-Q
37	08-04-2015	06-30-2015	10-Q
38	05-04-2015	03-31-2015	10-Q
39	02-13-2015	12-31-2014	10-K
40	11-06-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

heres-how-much-you-would-have-made-owning-vertex-pharmaceuticals-stock-in-the-last-20-years

Here's How Much You Would Have Made Owning...
09/06/2024 18:00:31

vertex-pharmaceuticalss-options-frenzy-what-you-need-to-know

Vertex Pharmaceuticals's Options Frenzy: W...
08/29/2024 19:16:08

jim-cramer-hold-on-to-builders-firstsource-heres-the-problem-with-viking-therapeutics

Jim Cramer: 'Hold On' To Builders FirstSou...
08/29/2024 12:42:52

Jim Cramer discusses Serve Robotics, Builders FirstSource, Vertex Pharmaceuticals and Viking Therapeutics on CNBC.

looking-into-vertex-pharmaceuticalss-recent-short-interest

Looking Into Vertex Pharmaceuticals's Rece...
08/27/2024 16:45:14

unpacking-the-latest-options-trading-trends-in-vertex-pharmaceuticals

Unpacking the Latest Options Trading Trend...
08/23/2024 18:05:09

if-you-invested-100-in-this-stock-20-years-ago-you-would-have-4900-today

If You Invested $100 In This Stock 20 Year...
08/21/2024 16:30:20

nsa-code-breaker-jim-simons-hedge-fund-renaissance-technologies--ozempic-wegovy-maker-novo-nordisk-along-with-nvidia-palantir-among-top-holdings

NSA Code Breaker Jim Simons' Hedge Fund Re...
08/20/2024 02:25:30

Renaissance Technologies, the hedge fund founded by legendary mathematician and former NSA code breaker Jim Simons, recently di...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
08/15/2024 17:35:23

Unpacking the Latest Options Trading Trend...
08/09/2024 18:45:55

Reported Earlier, Vertex Secures NHS Engla...
08/08/2024 06:00:36

- Eligible transfusion-dependent beta thalassemia (TDT) patients in England will be able to access the therapy from today - ...

HC Wainwright & Co. Maintains Buy on Verte...
08/05/2024 19:29:00

HC Wainwright & Co. analyst Andrew Fein maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price t...

Oppenheimer Maintains Outperform on Vertex...
08/05/2024 16:04:17

Oppenheimer analyst Hartaj Singh maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Outperform and raises the price targe...

JP Morgan Maintains Overweight on Vertex P...
08/05/2024 14:56:28

JP Morgan analyst Jessica Fye maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and raises the price target f...

Truist Securities Reiterates Buy on Vertex...
08/05/2024 14:19:22

Truist Securities analyst Joon Lee reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price target fr...

Barclays Downgrades Vertex Pharmaceuticals...
08/05/2024 10:49:47

Barclays analyst Gena Wang downgrades Vertex Pharmaceuticals (NASDAQ:VRTX) from Overweight to Equal-Weight and raises the pr...

Guggenheim Maintains Buy on Vertex Pharmac...
08/02/2024 19:34:23

Guggenheim analyst Debjit Chattopadhyay maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Buy and raises the price targe...

magnificent-7-lose-over-300b-as-volatility-index-surges-traders-question-feds-timing-whats-driving-markets-friday

Magnificent 7 Lose Over $300B As Volatilit...
08/02/2024 17:49:33

Wall Street is experiencing a sharp decline on the last trading day of the week, with all indices in the red at noon in New Yor...

vertex-pharmaceuticals-lifts-annual-guidance-positive-growth-for-its-cystic-fibrosis-franchise-and-pain-management-pipeline

Vertex Pharmaceuticals Lifts Annual Guidan...
08/02/2024 17:48:19

Vertex Pharmaceuticals reported Q2 revenues of $2.65B, near the $2.66B estimate, with an adjusted EPS loss of $(12.83), missing...

Cantor Fitzgerald Reiterates Overweight on...
08/02/2024 14:57:10

Cantor Fitzgerald analyst Olivia Brayer reiterates Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and maintains $480...

Piper Sandler Maintains Overweight on Vert...
08/02/2024 14:04:04

Piper Sandler analyst Christopher Raymond maintains Vertex Pharmaceuticals (NASDAQ:VRTX) with a Overweight and raises the pr...